These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31355278)

  • 1. IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc Pathway.
    Chu J; Li Y; Deng Z; Zhang Z; Xie Q; Zhang H; Zhong W; Pan B
    Biomed Res Int; 2019; 2019():7201562. PubMed ID: 31355278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.
    Ciccarelli C; Di Rocco A; Gravina GL; Mauro A; Festuccia C; Del Fattore A; Berardinelli P; De Felice F; Musio D; Bouché M; Tombolini V; Zani BM; Marampon F
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1685-1699. PubMed ID: 29959569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin targets c-MYC oncogene to prevent prostate cancer.
    Akinyeke T; Matsumura S; Wang X; Wu Y; Schalfer ED; Saxena A; Yan W; Logan SK; Li X
    Carcinogenesis; 2013 Dec; 34(12):2823-32. PubMed ID: 24130167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of IGHG1 gene expression by siRNA leads to growth inhibition and apoptosis induction in human prostate cancer cell.
    Pan B; Zheng S; Liu C; Xu Y
    Mol Biol Rep; 2013 Jan; 40(1):27-33. PubMed ID: 23117283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
    Tan Y; Wang L; Du Y; Liu X; Chen Z; Weng X; Guo J; Chen H; Wang M; Wang X
    Int J Oncol; 2018 Dec; 53(6):2503-2517. PubMed ID: 30272279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
    Guo Z; Liu D; Su Z
    Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal signaling promotes a tumorigenic phenotype in human breast cancer.
    Kirsammer G; Strizzi L; Margaryan NV; Gilgur A; Hyser M; Atkinson J; Kirschmann DA; Seftor EA; Hendrix MJ
    Semin Cancer Biol; 2014 Dec; 29():40-50. PubMed ID: 25073112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of IGHG1 promotes breast cancer malignant development by activating the AKT pathway.
    Jin Y; Qiu L; Bao W; Lu M; Cao F; Ni H; Zhao B
    Cell Cycle; 2023; 22(6):718-731. PubMed ID: 36404682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression.
    Chang C; Liu J; He W; Qu M; Huang X; Deng Y; Shen L; Zhao X; Guo H; Jiang J; Fu XY; Huang R; Zhang D; Yan J
    Oncogene; 2018 Jan; 37(4):415-426. PubMed ID: 28967902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
    Guo Z; Liu D; Su Z
    Tumour Biol; 2015 May; 36(5):3583-9. PubMed ID: 25560487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
    Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
    Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Karyopherin beta 1 suppresses prostate cancer growth.
    Yang J; Guo Y; Lu C; Zhang R; Wang Y; Luo L; Zhang Y; Chu CH; Wang KJ; Obbad S; Yan W; Li X
    Oncogene; 2019 Jun; 38(24):4700-4714. PubMed ID: 30742095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.
    Yin H; Sheng Z; Zhang X; Du Y; Qin C; Liu H; Dun Y; Wang Q; Jin C; Zhao Y; Xu T
    Oncol Rep; 2017 Feb; 37(2):1045-1051. PubMed ID: 27922675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-Regulation of Nfatc1 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Prostate Cancer Cells.
    Liu Y; Liang T; Qiu X; Ye X; Li Z; Tian B; Yan D
    Med Sci Monit; 2019 Feb; 25():1572-1581. PubMed ID: 30817743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40.
    Wang D; Zhu L; Liao M; Zeng T; Zhuo W; Yang S; Wu W
    Oncol Rep; 2016 Sep; 36(3):1285-92. PubMed ID: 27431378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells.
    Wang J; Anderson PD; Luo W; Gius D; Roh M; Abdulkadir SA
    Oncogene; 2012 Apr; 31(14):1794-803. PubMed ID: 21860423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSCA promotes prostate cancer proliferation and cell-cycle progression by up-regulating c-Myc.
    Li E; Liu L; Li F; Luo L; Zhao S; Wang J; Kang R; Luo J; Zhao Z
    Prostate; 2017 Dec; 77(16):1563-1572. PubMed ID: 28971496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting SMYD2 inhibits prostate cancer cell growth by regulating c-Myc signaling.
    Li J; Wan F; Zhang J; Zheng S; Yang Y; Hong Z; Dai B
    Mol Carcinog; 2023 Jul; 62(7):940-950. PubMed ID: 37036190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.